Literature DB >> 30186994

Severe infolding of fenestrated-branched endovascular stent graft.

Aleem K Mirza1, Giuliano A Sandri1, Emanuel R Tenorio1, Jussi M Kärkkäinen1, Gustavo S Oderich1.   

Abstract

Infolding of a fenestrated-branched stent graft is an infrequent complication due to excessive oversizing. We report the case of an 89-year-old man who underwent a four-vessel fenestrated-branched endovascular aortic repair for a pararenal aortic aneurysm. Computed tomography angiography revealed severe infolding across the mesenteric-renal vessels. The patient was treated by angioplasty and placement of Palmaz stent. Cone-beam computed tomography confirmed patent visceral vessels with resolution of the infolding. This case illustrates an uncommon complication that can be prevented by modifications in the stent design and by immediate assessment using intraoperative cone-beam computed tomography.

Entities:  

Keywords:  Cone-beam computed tomography (CBCT); Fenestrated-branched endovascular stent graft; Infolding

Year:  2018        PMID: 30186994      PMCID: PMC6122380          DOI: 10.1016/j.jvscit.2018.05.001

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


Endovascular repair of complex aortic aneurysms is increasing in frequency with wider application of fenestrated and branched stent graft technology.1, 2, 3 For patients with juxtarenal or pararenal aortic aneurysms, stents are often designed with a supraceliac sealing zone using three or four fenestrations. The presence of a narrowing segment at the level of the renal arteries may result in excessive oversizing if the device is planned to the sealing zone at the level of the superior mesenteric artery (SMA) and celiac axis. Problems associated with excessive oversizing include difficult device rotation, lack of space to facilitate branch catheterization, and rarely infolding. This report illustrates a patient who had an unrecognized stent graft infolding at the time of initial stent graft implantation. The technique of endovascular treatment of fenestrated stent graft infolding is described. The patient was informed and consented to the writing of this report.

Case report

The patient is an 89-year-old man with an enlarging 6.1-cm pararenal abdominal aortic aneurysm with a penetrating aortic ulcer adjacent to the left renal artery. Computed tomography angiography revealed a suitable sealing zone of 27 mm in diameter at the level of the suprarenal aorta, with narrowing of the aortic diameter to 20 mm below the lowest renal artery. His cardiovascular risk factors included hypertension, hyperlipidemia, coronary artery disease, and remote smoking history. The patient had a paternal family history of abdominal aortic aneurysm. A fenestrated-branched stent graft was designed with a double scallop for the celiac axis and three fenestrations for the SMA and both main renal arteries. The stent graft sealing stents were sized to 32 mm, with stent graft taper to 22 mm starting below the level of the lowest fenestration. Using bilateral percutaneous femoral approach and a preloaded renal guidewire system, the fenestrated repair was deployed without complications. The SMA and both renal arteries were aligned using iCAST covered stents (Atrium Medical, Hudson, NH), which were flared to 10 mm. Completion angiography revealed widely patent celiac axis, SMA, and bilateral renal arteries with no evidence of endoleak. The patient recovered without complications and underwent routine predismissal computed tomography angiography (CTA) on postoperative day 1. CTA revealed severe infolding of the proximal aortic sealing stent, starting at the level of celiac axis scallop and extending distally across the SMA and renal fenestrations (Fig 1). The infolded stent graft had no apposition to the posterior aortic wall, resulting in a large type IA endoleak.
Fig 1

Infolding of fenestrated stent graft due to excessive oversizing caused a type I endoleak. SMA, Superior mesenteric artery.

Infolding of fenestrated stent graft due to excessive oversizing caused a type I endoleak. SMA, Superior mesenteric artery.

Technique

The patient was treated for the stent graft infolding under general endotracheal anesthesia using bilateral percutaneous transfemoral approach in a hybrid endovascular operating room with cone-beam computed tomography (CBCT) capability. A 20F Gore DrySeal sheath (W. L. Gore & Associates, Flagstaff, Ariz) was advanced through the left femoral approach and a 14F Cook Check-Flo sheath (Cook Medical, Bloomington, Ind) through the right femoral approach. The SMA and bilateral renal arteries were selectively catheterized using separate 7F hydrophilic sheaths and Rosen guidewires (Cook Medical). Angioplasty balloons (10 mm × 2 cm) were positioned into each of the three fenestrations for kissing balloon inflation. First, a 49-mm × 10-cm Palmaz stent (Cordis Endovascular, Milpitas, Calif) was positioned and deployed just proximal to the SMA fenestration and across the celiac axis scallop to expand the proximal sealing stent. The Palmaz stent was postdilated to 25 mm through the left femoral approach to re-expand the top sealing stent of the fenestrated aortic stent graft. Once the sealing stent was fully expanded, the balloon was used to dilate the segment across the SMA and renal arteries with concomitant balloon inflation of all three fenestrated stents. The aortic balloon was deflated first, followed by angioplasty of the SMA and renal stents. Completion angiography revealed a widely patent celiac axis, SMA, and bilateral renal arteries with no evidence of endoleak. Intravascular ultrasound was performed and demonstrated a completely expanded stent graft. CBCT confirmed that all stents were fully expanded with no residual infolding (Fig 2). The patient tolerated the procedure well and was discharged on postoperative day 2 with a normal serum creatinine concentration of 0.9 mg/dL and no complications. CTA at 1 year showed a widely patent stent graft with small type II endoleak.
Fig 2

Infolded aortic stent across the fenestrated segment (A) requires protection of each of the side stents by sheath and balloon (B). Placement of a Palmaz stent in the proximal sealing stent (C) followed by dilation of the visceral segment of the graft (D), balloon dilation of each side stent (E), and the aorta (F) allows complete expansion of the aortic graft (G).

Infolded aortic stent across the fenestrated segment (A) requires protection of each of the side stents by sheath and balloon (B). Placement of a Palmaz stent in the proximal sealing stent (C) followed by dilation of the visceral segment of the graft (D), balloon dilation of each side stent (E), and the aorta (F) allows complete expansion of the aortic graft (G).

Discussion

Fenestrated and branched endografts have broadened the indications of endovascular aortic repair to patients with complex aneurysms involving the renal and mesenteric arteries.4, 5 In most centers with larger experience, fenestrated stent grafts have evolved from two fenestrations to three or four fenestrations based on supraceliac sealing zones. This change in design paradigm has occurred because of risk of progression of aortic disease, which may compromise sealing zone in patients treated by two fenestrations. Despite the increasing complexity in design, outcomes with three or four fenestrations have been satisfactory, with no change in technical success, mortality, and major adverse events.1, 2, 3 Type IA endoleaks after fenestrated endovascular aneurysm repair are infrequent, particularly if supraceliac sealing zone is used.2, 4, 6 O'Callaghan et al reported a large experience with 924 patients, of whom 26 (2.8%) had type IA endoleak after fenestrated repair. In that study, use of more fenestrations was associated with significant decline in the rate of type IA endoleak. Once a type IA endoleak is present, treatment is recommended, but options may be limited to stent graft explantation or redo fenestrated-branched repair if there is progression of disease compromising seal.8, 9 In the U.S. Zenith Fenestrated Study, one patient (1.5%) developed a late type IA endoleak treated by coil embolization at 3 years of follow-up. Fenestrated stent graft infolding is a rare complication with no previous reports in the literature. This may be due to excessive stent graft oversizing, which can occur if there is a narrower aortic segment below the sealing zone. Fenestrated stent grafts have been traditionally designed with a tapered segment below the lowest renal fenestration so that the fenestrations are as close as possible to the target vessel. In patients with juxtarenal aneurysms, the infrarenal aorta may be excessively narrow compared with the sealing zone at the level of the SMA and suprarenal aorta (Fig 3). This may be a cause of infolding, which can be prevented by designing the fenestrated endograft with a tapered segment across the fenestrations to better match the aortic diameter.
Fig 3

Fenestrations have been based on wider graft diameters to promote apposition between the graft fabric and the aortic wall. Some designs may start the tapered segment in the superior mesenteric artery (SMA), ending below the renal arteries (A), or use the traditional design of rapid tapering below the renals (B). The design illustrated in (A) could have avoided the infolded aortic stent in this case.

Fenestrations have been based on wider graft diameters to promote apposition between the graft fabric and the aortic wall. Some designs may start the tapered segment in the superior mesenteric artery (SMA), ending below the renal arteries (A), or use the traditional design of rapid tapering below the renals (B). The design illustrated in (A) could have avoided the infolded aortic stent in this case. Treatment of infolding requires dilation of the aortic endograft, which has to be done with caution to avoid uncontrolled aortic disruption. For this reason, we elected to start the revision by expanding the proximal sealing stent with a Palmaz stent graft, ensuring at least expansion of the proximal stent and resolution of the type IA endoleak. Once the stent was expanded, the renal and mesenteric segments were dilated with balloon protection of the visceral vessels to prevent side branch stent compression or occlusion. Our report also illustrates the utility of performing immediate assessment with CBCT, which was not done at the time of the initial implant. Intraoperative assessment with CBCT ensures immediate identification of stent kink, compression or infolding, and endoleaks and may decrease the rate of avoidable reinterventions as illustrated by this case.11, 12

Conclusions

This case illustrates a technique for repair of fenestrated stent graft infolding with a Palmaz stent while preventing side stent compression. It also highlights the role of CBCT in ensuring aortic and visceral stent graft patency.
  12 in total

1.  Type Ia endoleaks after fenestrated and branched endografts may lead to component instability and increased aortic mortality.

Authors:  Adrian O'Callaghan; Roy K Greenberg; Matthew J Eagleton; James Bena; Tara Marie Mastracci
Journal:  J Vasc Surg       Date:  2015-01-16       Impact factor: 4.268

2.  Prospective, nonrandomized study to evaluate endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts based on supraceliac sealing zones.

Authors:  Gustavo S Oderich; Mauricio Ribeiro; Jan Hofer; Jean Wigham; Stephen Cha; Julia Chini; Thanila A Macedo; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2016-12-13       Impact factor: 4.268

3.  Intraoperative proximal endoleaks during AAA stent-graft repair: evaluation of risk factors and treatment with Palmaz stents.

Authors:  N V Dias; T Resch; M Malina; B Lindblad; K Ivancev
Journal:  J Endovasc Ther       Date:  2001-06       Impact factor: 3.487

4.  Fenestrated Endovascular Aortic Aneurysm Repair as a First Line Treatment Option to Treat Short Necked, Juxtarenal, and Suprarenal Aneurysms.

Authors:  E L G Verhoeven; A Katsargyris; K Oikonomou; G Kouvelos; H Renner; W Ritter
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-02-06       Impact factor: 7.069

5.  Intra-operative cone beam computed tomography can help avoid reinterventions and reduce CT follow up after infrarenal EVAR.

Authors:  P Törnqvist; N Dias; B Sonesson; T Kristmundsson; T Resch
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-02-27       Impact factor: 7.069

6.  Outcomes of endovascular AAA repair in patients with hostile neck anatomy using adjunctive balloon-expandable stents.

Authors:  Daniel E Cox; Donald L Jacobs; Raghunandan L Motaganahalli; Catherine M Wittgen; Gary J Peterson
Journal:  Vasc Endovascular Surg       Date:  2006 Jan-Feb       Impact factor: 1.089

7.  Twelve-year results of fenestrated endografts for juxtarenal and group IV thoracoabdominal aneurysms.

Authors:  Tara M Mastracci; Matthew J Eagleton; Yuki Kuramochi; Shona Bathurst; Katherine Wolski
Journal:  J Vasc Surg       Date:  2015-02       Impact factor: 4.268

8.  Midterm results from a physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts for the treatment of juxtarenal aortic aneurysms.

Authors:  Benjamin W Starnes; Rachel E Heneghan; Billi Tatum
Journal:  J Vasc Surg       Date:  2016-09-26       Impact factor: 4.268

9.  Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal aortic aneurysms.

Authors:  Gustavo S Oderich; Roy K Greenberg; Mark Farber; Sean Lyden; Luis Sanchez; Ron Fairman; Feiyi Jia; Priya Bharadwaj
Journal:  J Vasc Surg       Date:  2014-09-05       Impact factor: 4.268

10.  Early report from an investigator-initiated investigational device exemption clinical trial on physician-modified endovascular grafts.

Authors:  Benjamin Ware Starnes; Billi Tatum
Journal:  J Vasc Surg       Date:  2013-05-03       Impact factor: 4.268

View more
  1 in total

1.  Utility of dual longitudinal diameter-reducing ties in aortic arch thoracic endovascular aortic repair.

Authors:  Arkadiusz Kazimierczak; Paweł Rynio; Tomasz Jędrzejczak; Maciej Lewandowski; Piotr Gutowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-08       Impact factor: 1.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.